An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.

MH Trivedi, ME Thase, O Osuntokun… - Journal of Clinical …, 2009 - psychiatrist.com
Objective: To evaluate the efficacy of olanzapine/fluoxetine combination (OFC) versus
olanzapine or fluoxetine monotherapy across all clinical trials of treatment-resistant …

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram)

CH Mallinckrodt, A Prakash, JP Houston… - …, 2008 - karger.com
Objective: To test the hypothesis that in patients with major depressive disorder (MDD), the
response for specific Hamilton Depression Rating Scale items will differ for duloxetine …

Is lithium in a class of its own? A brief profile of its clinical use

GS Malhi, D Adams, M Berk - Australian & New Zealand …, 2009 - journals.sagepub.com
Lithium is a unique and effective psychotropic agent with a long-standing history of clinical
use yet it is increasingly overlooked in lieu of newer agents. The purpose of the present …

Antidepressant‐Resistant Depression and Antidepressant‐Associated Suicidal Behaviour: The Role of Underlying Bipolarity

Z Rihmer, X Gonda - Depression research and treatment, 2011 - Wiley Online Library
The complex relationship between the use of antidepressants and suicidal behaviour is one
of the hottest topics of our contemporary psychiatry. Based on the literature, this paper …

THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS'PRACTICE PATTERNS FOR THE TREATMENT …

JF Goldberg, MP Freeman, R Balon… - Depression and …, 2015 - Wiley Online Library
Background Optimal successive treatment decisions are not well established after an initial
medication nonresponse in major depressive disorder or bipolar disorder. While practice …

Melatonin produces a rapid onset and prolonged efficacy in reducing depression-like behaviors in adult rats exposed to chronic unpredictable mild stress

X Sun, M Wang, Y Wang, B Lian, H Sun, G Wang… - Neuroscience …, 2017 - Elsevier
The present study was aimed at evaluating the rapidity and duration of melatonin as an
antidepressant in a rat model of depression. The rats were subjected to a six-week period of …

Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.

MH Trivedi, ME Thase, M Fava, JC Nelson… - Journal of Clinical …, 2008 - psychiatrist.com
Objective: To evaluate the efficacy of adjunctive aripiprazole to standard antidepressant
therapy (ADT) for patients with DSM-IV major depressive disorder with anxious/atypical …

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

RM Berman, ME Thase, MH Trivedi… - Neuropsychiatric …, 2011 - Taylor & Francis
Background: Effective management of major depressive disorder often includes the long-
term use of multiple medications, and the longer-term utility and safety of adjunctive …

A randomized, double-blind, placebo-controlled, 12-week trial of vitamin D augmentation in major depressive disorder associated with vitamin D deficiency

PNS Kumar, V Menon, C Andrade - Journal of Affective Disorders, 2022 - Elsevier
Abstract Background Randomized controlled trials (RCTs) of vitamin D (VitD)
supplementation for depression have yielded inconsistent results. We conducted the first …

Melatonin synergizes with citalopram to induce antidepressant‐like behavior and to promote hippocampal neurogenesis in adult mice

G Ramírez‐Rodríguez, NM Vega‐Rivera… - Journal of pineal …, 2014 - Wiley Online Library
Adult hippocampal neurogenesis is affected in some neuropsychiatric disorders such as
depression. Numerous evidence indicates that plasma levels of melatonin are decreased in …